Student-focused New York-based Mantra Health recently unveiled a new programme to support people with bipolar I disorder, just over a year after adding support for patients with bipolar II disorder to its platform.
The healthtech company is offering the solution as part of an integration with its customers’ university health services, paving the way towards a collaborative model for mental health in the academic world.
Through this integration, students with bipolar I will now have access to a holistic mental health solution, including remote therapy sessions. They will also be able to benefit from ongoing symptom screenings between appointments, as well as texting telehealth providers with any questions, or sharing information with university health clinicians.
The platform can detect symptoms such as psychosis and other conditions, effectively acting as a proactive solution, and can then transfer the patient to in-person providers without delay.
The comprehensive remote solution is crucial to the nature of bipolar I, which can induce psychosis or other conditions, which require immediate attention for an optimal patient outcome.
According to the CDC, bipolar I disorder, also known as manic-depressive illness, causes individuals to experience both manic and depressive episodes. This disorder differs from bipolar II disorder, where individuals experience less severe mania.
Approximately 2.8% of American adults have suffered from bipolar disorder in the past year alone. This disorder is most prevalent among people between the ages of 18 and 29. In fact, 4.7 percent of people in this age group are living with the disorder, according to NIH reports.
Mantra Health strives to help people affected by serious mental health problems manage them more effectively.
Ed Gaussen, co-founder and CEO of the healthtech company, explained in a statement how adding bipolar I disorder management to the platform will make a significant difference in the lives of not only the students Mantra Health serves, but also its higher education partners. He went on to highlight how the successful treatment of emerging bipolar disorder in college-aged patients often materially improves their chances of graduation and ultimately their long-term quality of life.
Launched in 2018, in just 3 years, the company is currently leading the academic mental health sphere. After receiving $2 million in 2020, the company secured an extension of seed funding this year, bringing its total funds raised to $5.2 million today.
As the need for remote mental health care grows, so does the competition, in fact the sphere counts 67 venture capital deals as of 2020, equating to a staggering $2.4bn in mental healthtech deals.